2018 | Intestinal P-glycoprotein inhibitors, benzoxanthone analogues | 이화정; 권영주; 이재옥 | Article |
2018 | Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors | 권영주 | Article |
2014 | Reply to the Letter to the Editor "Cobalt-albumin binding (CAB) assay: An advantageous and flaw free testing of albumin-cobalt binding" | 권영주 | Letter |
2015 | Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines | 권영주 | Article |
2012 | Neuroprotective effect of undecylenic acid extracted from Ricinus communis L. through inhibition of μ-calpain | 권영주; 전규연 | Article |
2012 | Dihydroxylated 2,4,6-triphenyl pyridines: Synthesis, topoisomerase i and II inhibitory activity, cytotoxicity, and structure-activity relationship study | 권영주 | Article |
2012 | A facile synthesis of emodin derivatives, emodin carbaldehyde, citreorosein, and their 10-deoxygenated derivatives and their inhibitory activities on μ-calpain | 권영주 | Article |
2010 | New benzoxanthone derivatives as topoisomerase inhibitors and DNA cross-linkers | 권영주 | Article |
2011 | Chalcones as novel non-peptidic μ-calpain inhibitors | 권영주 | Article |
2018 | Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/II alpha inhibitors | 권영주 | Article |